Welcome to IthaMaps
IthaMaps is a global epidemiology database of heamoglobinopathies, illustrating published data on a dynamic global to regional map. Country-specific information on haemoglobinopathy-related policies, prevalence, incidence and overall disease burden is given, including relative allele frequencies of specific globin mutations in each country and/or region, dynamically linked to corresponding IthaGenes entries.
IthaMaps content was supported by partnership with the HVP Global Globin 2020 Challenge
Search
General information for Iraq
Iraq |
|
---|
Haemoglobinopathy-specific healthcare policy information for Iraq
Healthcare policy | Comment/Info | Reference | |
---|---|---|---|
Prevention programme: | Yes (Regional) | Based on premarital screening the Kurdistan region in northern Iraq since 2008. | [PMID: 23224852] |
SCD newborn screening: | No | SCD is not included in the neonatal screening program [From: IJCCS, 2016, 4(2):40] | |
Prenatal screening: | Yes (Regional) | E.g.: Sulaymaniyah, Northeastern Iraq | [PMID: 24144846] |
Iron chelation availability: | Yes (National) | Oral chelation therapy (deferasirox) is provided free of charge by the Ministry of Health to all thalassemia centers in the country. | |
Patient associations: | Yes (National) | E.g.: DIWANYAH Thalassaemia Association, Iraqi Thalassaemia Association. | |
Genetic counselling: | Yes (Regional) | As part of the prevention programme. | [PMID: 11773575] |
Prevalence and incidence of major haemoglobinopathies in Iraq
Haemoglobinopathy | Comment/Info | Reference | |
---|---|---|---|
Prevalence of β-thalassaemia carriers: | 4.8 % of the population | [PMID: 24672827] | |
Prevalence of sickle cell disease carriers: | 0.7 % of the population | Varies from 0% to 16%, with high prevalence in the extreme north and south of the country. | [PMID: 24672827] |
Prevalence of α-thalassaemia carriers: | 1 % of the population | Data representative of Baghdad. | [PMID: 23224852] |
Expected incidence of β-thalassaemia: | 502 expected affected births/year | [PMID: 24672827] | |
Expected incidence of sickle cell disease: | 157 expected affected births/year | [PMID: 24672827] | |
Incidence of sickle cell disease: | 629 affected births/year | Median value estimated using statistical model and demographic data. | [PMID: 23103089] |
Known β-thalassaemia patients: | 10808 patients | [PMID: 24672827] | |
Known sickle cell disease patients: | 3620 patients | [PMID: 24672827] |
Global Burden of Disease data for Iraq
Migration data for Iraq
Mutation frequencies in Iraq
Overview (most frequent mutations with their observed average values and range)
β-locus
IVS II-1 G>A: 29.65 % (17.6 % – 47.2 %) | IVS I-6 (T>C): 20.76 % (3.9 % – 35.8 %) |
IVS I-110 G>A: 11.64 % (1.4 % – 30.1 %) | CD 8 (-AA): 6.61 % (0.97 % – 15.4 %) |
Detailed mutation frequencies
Entry ID | Locus | Region | Ethnic Group | Population Type | Sample Size | Study period (from) | Study period (to) | Reference | Comments | |
---|---|---|---|---|---|---|---|---|---|---|
23343 | β-locus | Baghdad | Iraqi Arabs | Patients | 201 | 2015 | 25751242 | Frequencies are shown for beta-globin gene mutations and were re-calculated by Ithanet. Samples represent thalassaemia intermedia patients registered at the Ibn Albaladi hereditary anemia center in Baghdad. | ||
23344 | β-locus | Sulaymaniyah | Kurds | Patients | 318 | 0000 | 0000 | 32190657 | Frequencies are shown for beta-globin gene mutations. Samples were collected from the Sulaymaniyah Thalassaemia Care Center. | |
23345 | β-locus | Baghdad | Arab | Carriers | 103 | 2013 | 23826747 | Frequencies are shown for beta-globin gene mutations. Study samples were acquired from the Ibn Al-Balady Thalassemia Centre in Baghdad. | ||
23346 | β-locus | Sulaymaniyah | Kurds | Carriers | 123 | 2008 | 2008 | 20854121 | Frequencies are shown for beta-globin gene mutations. Study samples were acquired from the Sulaimaniyah Province in northeastern Iraq. | |
23347 | β-locus | Erbil | Iraqi Kurds | Patients | 166 | 2015 | 25902180 | Frequencies are shown for beta-globin gene mutations. Study subjects represent thalassaemia intermedia patients from the Erbil Thalassaemia Care Centre, Erbil. | ||
23348 | β-locus | Duhok | Iraqi | Patients | 148 | 2014 | 24719849 | Frequencies are shown for beta-globin gene mutations and were calculated by Ithanet. Study samples represent beta-thalassaemia intermedia patients at the Duhok thalassaemia care centre, Duhok, in Northern Iraq. |
Organisations in Iraq
A list of all organisations in Iraq stored in the ITHANET database is shown below. For more information, click on the corresponding organisation name or visit the detailed ITHANET Organisations page
Name | Department | Organisation type |
---|---|---|
Hiwa Hematology Oncology Hospital | Sulaimaniya Thalassemia, Hemophilia and Congenital Blood Disorders Center | Medical Center |
Microattributions
No microattibutions were provided for Iraq. Please contact us, if you are willing to review existing information or provide new data.
To provide new epidemiological information and/or report mistakes, please register/log in first or use the Contact Us form.
Important Note: The relative allele frequencies presented in IthaMaps are not calculated by ITHANET, but they are extracted from the corresponding publications. ITHANET is not responsible for any mistakes in the data. Please use this information with caution! We encourage scientists that have more detailed or updated epidemiological information to contact us.
Disclaimer: The information on this website is provided as an information resource only and must not to be used as a substitute for professional diagnosis and treatment. The ITHANET Portal and IthaMaps are not responsible or liable for any advice, course of treatment, diagnosis or any other information, services or products that an individual obtains through this website.